COVID-19
Conditions
Interventions
Covid test kit
Sponsors
Medical Research Council Unit The Gambia at LSHTM
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adults and children of both genders without age limit being either suspect of COVID-19, or contacts of a confirmed COVID-19 patient following the WHO case definitions below, are eligible to participate in the study
Exclusion criteria
Exclusion criteria: - The subject (or parents/guardians for minors<18y) has not provided individual informed consent for the study; - The patient has already been sampled and is waiting for the results;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. To validate a commercially available antigen-based rapid diagnostic test in suspected COVID-19 patients; 2. To develop a validated serology platform for determining serostatus and monitoring immune responses to SARS-CoV-2 infection; 3. To characterize the viral load and antibody dynamics in a cohort of confirmed COVID-19 patients; 4. To characterize at household level the sero-epidemiology of COVID-19 infections; 5. To determine the performance of saliva for the detection of SARS-CoV-2 RNA and antibodies in COVID-19 patients; 6. To determine the duration and infectivity of viral shedding in COVID-19 patients; | — |
Secondary
| Measure | Time frame |
|---|---|
| To contribute to the COVID-19 response in WA by improving local diagnostic and surveillance capabilities. | — |
Countries
Gambia
Contacts
Public ContactVivat Thomas Njie
Department of Clinical Trials Coordinator
Outcome results
None listed